Joyce, C. and Boyd, M. and Sorensen, A. and Tesson, M. and Babich, J. W. and Mairs, R. J. (2012) The use of targeted radionuclide therapy for the treatment of malignant melanoma in vivo. Mutagenesis, 27 (1). p. 110. ISSN 0267-8357
Full text not available in this repository. (Request a copy from the Strathclyde author)Official URL: http://dx.doi.org/10.1093/mutage/ger068
Abstract
This study investigates the potential of the noradrenaline analogue [131I]MIBG (metaiodobenzylguanidine) and the novel melanin binding benzamide [131I] Solazed for melanoma therapy in vivo and in vitro.
| Item type: | Article |
|---|---|
| ID code: | 40173 |
| Keywords: | targeted radionuclide therapy, treatment, malignant melanoma , in vivo, in vitro, noradrenaline analogue , metaiodobenzylguanidine, Pharmacy and materia medica |
| Subjects: | Medicine > Pharmacy and materia medica |
| Department: | Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences |
| Related URLs: | |
| Depositing user: | Pure Administrator |
| Date Deposited: | 22 Jun 2012 12:06 |
| Last modified: | 10 Apr 2013 10:36 |
| URI: | http://strathprints.strath.ac.uk/id/eprint/40173 |
Actions (login required)
| View Item |